Form D · Pharmaceuticals

NUON THERAPEUTICS INC

San Mateo, CA · CIK 0001432580

Offering snapshot reported Aug 11, 2010 · SEC filing

Reported sold: $10M
Investors reported: 9
Minimum accepted: $0
First sale: Aug 5, 2010

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 11, 2010	Initial	$9,999,999	No comparison	9	SEC filing
Mar 17, 2010	Initial	$6,053,189	No comparison	6	SEC filing
Aug 25, 2009	Initial	$13,662,500	No comparison	0	SEC filing
Apr 11, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired, Other
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-146233

Sale and issuance of (i) convertible promissory notes, convertible into shares of Equity Securities, (ii) warrants exercisable for Series B Preferred Stock, and (iii) the underlying shares of common stock issuable upon conversion of (i) and (ii)

Source: Form D, filed Aug 11, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Paulette Dillon	Executive
Joshua Funder	Director
Josh Funder	Director
Helen Jenkins	Executive
Kim Kamdar	Director
Michael Kitt	Executive
Robert More	Director
Bob More	Director
Arlene Morris	Director
Rodney Pearlman	Director, Executive
Lee Rauch	Director, Executive
Tito Serafini	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

2755 Campus Drive Suite 175
San Mateo, CA, 94403